Literature DB >> 23818323

Public hospital autonomy in China in an international context.

Pauline Allen1, Qi Cao, Hufeng Wang.   

Abstract

Following decades of change in health care structures and modes of funding, China has recently been making pilot reforms to the governance of its public hospitals, primarily by increasing the autonomy of public hospitals and redefining the roles of the health authorities. In this paper, we analyse the historical evolution and current situation of public hospital governance in China, focussing the range of governance models being tried out in pilot cities across China. We then draw on the experiences of public hospital governance reform in a wide range of other countries to consider the nature of the Chinese pilots. We find that the key difference in China is that the public hospitals in the pilot schemes do not receive sufficient funding from government and are able to distribute profits to staff. This creates incentives to charge patients for excessive treatment. This situation has undermined public service orientation in Chinese public hospitals. We conclude that the pilot reforms of governance will not be sufficient to remedy all the problems facing these hospitals, although they are a step in the right direction.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  China; autonomy; governance; public hospitals; reform

Mesh:

Year:  2013        PMID: 23818323     DOI: 10.1002/hpm.2200

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  10 in total

1.  The scale and structure of government financial investment in traditional medicine based on optimal efficiency: evidence from public traditional Chinese medicine hospitals (PTHs) of Henan province, China.

Authors:  Weicun Ren; Xiaoli Fu; Clifford Silver Tarimo; Maisa Kasanga; Yanqing Wang; Jian Wu
Journal:  BMC Health Serv Res       Date:  2021-02-26       Impact factor: 2.655

Review 2.  China's Elder Care Policies 1994-2020: A Narrative Document Analysis.

Authors:  Marion F Krings; Jeroen D H van Wijngaarden; Shasha Yuan; Robbert Huijsman
Journal:  Int J Environ Res Public Health       Date:  2022-05-18       Impact factor: 4.614

3.  Development of the Chinese version of the Hospital Autonomy Questionnaire: a cross-sectional study in Guangdong Province.

Authors:  Zifeng Liu; Lianxiong Yuan; Yixiang Huang; Lingling Zhang; Futian Luo
Journal:  BMJ Open       Date:  2016-02-24       Impact factor: 2.692

4.  What do patients care most about in China's public hospitals? Interviews with patients in Jiangsu Province.

Authors:  Xuanxuan Wang; Rongqin Jiang; Jingxian Li; Jiaying Chen; Bo Burström; Kristina Burström
Journal:  BMC Health Serv Res       Date:  2018-02-08       Impact factor: 2.655

5.  Exploring pathways to outpatients' satisfaction with health care in Chinese public hospitals in urban and rural areas using patient-reported experiences.

Authors:  Xuanxuan Wang; Jiaying Chen; Bo Burström; Kristina Burström
Journal:  Int J Equity Health       Date:  2019-02-06

6.  Evaluating the Intention and Behaviour of Private Sector Participation in Healthcare Service Delivery via Public-Private Partnership: Evidence from China.

Authors:  Jie Yang; Lingchuan Song; Xiaoyi Yao; Qian Cheng; Zichao Cheng; Ke Xu
Journal:  J Healthc Eng       Date:  2020-01-16       Impact factor: 2.682

7.  Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space.

Authors:  Xiaoying Chen
Journal:  Health Care Anal       Date:  2021-11-11

8.  Equity and efficiency of public hospitals' health resource allocation in Guangdong Province, China.

Authors:  Wanmin Su; Liulin Du; Yujun Fan; Peixi Wang
Journal:  Int J Equity Health       Date:  2022-09-22

Review 9.  From Mao to McDonaldization? Assessing the rationalisation of health care in China.

Authors:  Ross Millar
Journal:  Sociol Health Illn       Date:  2021-08-12

Review 10.  Harnessing the privatisation of China's fragmented health-care delivery.

Authors:  Winnie Yip; William Hsiao
Journal:  Lancet       Date:  2014-08-30       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.